FDA authorizes Pfizer's Covid antiviral pill for people 12 and older
source link: https://www.engadget.com/fda-pfizer-covid-antiviral-pill-paxlovid-205104688.html
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.
FDA authorizes Pfizer's Covid antiviral pill for people 12 and older
The Paxlovid treatment could be available within a few days.
The FDA has issued an emergency authorization for Pfizer's antiviral pill Paxlovid, making it the first oral method for treating mild to moderate cases of COVID-19. The treatment is meant for high-risk people 12 and older who could progress to a more serious COVID infection. The best part? The FDA says it could be available to use within a few days, making it another tool as we face the Omicron variant wave.
Paxlovid is available by prescription only, and it's meant to be taken within five days of first noticing COVID symptoms. According to Pfizer's tests, it can prevent hospitalization or death by 88 percent in high-risk patients. The treatment, which can be prescribed to both vaccinated and unvaccinated people, consists of 30 pills taken over five days. It includes the protein inhibitor nirmatrelvir and rotinavir, which keeps that inhibitor from breaking down in your body. Side effects include an impaired sense of taste, high blood pressure, diarrhea and muscle aches.
“This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19," Dr. Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said in a statement.
So far, the US has ordered enough pills to treat 10 million people, the New York Times reports. The company plans to deliver enough pills to cover 65,000 Americans within a week. And after that, production is expect to ramp up, with 150,000 courses delivered in January and 150,000 in February. It also won't be the only antiviral pill around: Merck's competing treatment is expected to be approved soon, and it'll likely be more readily available than Pfizer's. Merck's option is far less effective, though—tests show it can only prevent hospitalization or death by 30 percent. (Still, that's better than having no treatment.)
Recommend
-
15
FDA authorizes Moderna's COVID-19 vaccine for emergency useFDA authorizes Moderna's COVID-19 vaccine for emergency useDarrell EtheringtonSat, December...
-
11
FDA Authorizes Moderna Covid-19 Vaccine for Emergency UseA sign announcing the beginning of immunizations against covid-19 at the Pittsburgh VA Medical Center on December 17, 2020 in Pittsburgh, Pennsylvania.Photo: Jeff Swensen (Getty Image...
-
3
CDC Director Statement on Pfizer’s Use of COVID-19 Vaccine in Adolescents Age 12 and Older Media StatementFor Immediate Release: May 12, 2021Contact:
-
8
Closer — FDA authorizes Pfizer COVID-19 vaccine for children 5-11 Before shots can go into little arms, the CDC will have to weigh in.
-
7
FDA authorizes 1st antiviral pill for COVID December 22, 202112:23 PM ET
-
6
FDA authorizes second COVID-19 antiviral pill Illustration by Alex Castro / The Verge The Food and Drug Administration
-
11
Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose...
-
6
official shots — FDA authorizes BA.4/5-targeting COVID boosters from Moderna and Pfizer The new boosters are expected to start going into arms around Labor Day. ...
-
6
Pfizer asks FDA to approve expansion of COVID booster eligibility to children ages 5 to 11 eligibility of its COVID-19 booster
-
8
data boost — Bivalent booster is 4x better against BA.5 in older adults, Pfizer says But the shots are only effective if people actually get them.
About Joyk
Aggregate valuable and interesting links.
Joyk means Joy of geeK